Harmony Biosciences Q3 Earnings Preview
Harmony Biosciences is scheduled to report Q3'26 results on November 4 before the market opens. Revenue and EPS estimates were provided.
Related stories
Nasdaq single-stock trading halt continues, symbol not given — reason not given (9:30 AM ET)
Nasdaq kept trading halted in a single listed security (reason not given) at 9:30 AM ET.
M impact | EQUITY | Nov 03, 2026, 02:46 PM UTC
EEE: trading halted on Nasdaq — volatility pause (9:30 AM ET)
Nasdaq halted trading in EEE (volatility pause) at 9:30 AM ET.
M impact | EQUITY | Nov 03, 2026, 02:40 PM UTC
RDACU: trading halted on Nasdaq — volatility pause (9:30 AM ET)
Nasdaq halted trading in RDACU (volatility pause) at 9:30 AM ET.
L impact | EQUITY | Nov 03, 2026, 02:40 PM UTC
Bank Of America Shares Hit 30-week Low
Bank Of America shares decreased to 49.22 USD, the lowest since April 2026. Over the past 4 weeks, Bank Of America lost 8.44%, and in the last 12 months, it decreased 7.69%.
L impact | EQUITY | Nov 03, 2026, 02:31 PM UTC
Dow Jones falls 206.75 points to 51,777.23 after open
M impact | EQUITY | Nov 03, 2026, 02:31 PM UTC
BETA Technologies Reports $17.67M Third-Quarter Revenue, Narrows Net Loss
Third-quarter 2026 revenue rose 98.2% year over year to $17.67 million. Net loss narrowed to $119.12 million from $451.81 million, while diluted loss per share was $0.51 versus $9.
M impact | EQUITY | Nov 03, 2026, 02:31 PM UTC